Director Marc Rubin receives 6,800 Curis (CRIS) stock options at $5.29
Filing Impact
Filing Sentiment
Form Type
4
Rhea-AI Filing Summary
Curis Inc. director Marc Rubin received a grant of stock options. He was awarded non-qualified options covering 6,800 shares of Curis common stock at an exercise price of $5.29 per share. The options vest 100% on July 7, 2027 and expire on July 6, 2036.
Positive
- None.
Negative
- None.
Insider Trade Summary
1 transaction reported
Mixed
1 txn
Insider
Rubin Marc
Role
Director
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Non Qualified Stock Option | 6,800 | $5.29 | $36K |
Holdings After Transaction:
Non Qualified Stock Option — 6,800 shares (Direct)
Footnotes (1)
- [object Object]
Key Figures
Options granted: 6,800 options
Exercise price: $5.29 per share
Underlying shares: 6,800 shares
+3 more
6 metrics
Options granted
6,800 options
Non-qualified stock option grant to director Marc Rubin
Exercise price
$5.29 per share
Exercise price for underlying Curis common stock
Underlying shares
6,800 shares
Curis common stock underlying the option grant
Vesting date
July 7, 2027
100% of underlying shares vest on this date
Expiration date
July 6, 2036
Option term end for this grant
Holdings after grant
6,800 options
Total derivative securities following this transaction
Key Terms
Non Qualified Stock Option, exercise price, vests as to 100% of the underlying shares, expiration date
4 terms
Non Qualified Stock Option financial
"security_title: "Non Qualified Stock Option""
exercise price financial
"conversion_or_exercise_price: "5.2900" per share"
The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.
expiration date financial
"expiration_date: "2036-07-06T00:00:00.000Z""
The expiration date is the deadline after which a financial contract, such as an option or a futures agreement, is no longer valid or can be exercised. It matters to investors because it determines the timeframe during which they can take action or benefit from the contract, similar to how a coupon or a food item has a limited period of usefulness. Once the expiration date passes, the contract loses its value or ability to be used.
FAQ
What insider transaction did Curis (CRIS) report for Marc Rubin?
Curis reported that director Marc Rubin received a grant of non-qualified stock options covering 6,800 shares of Curis common stock. These options were awarded as a compensation-related acquisition, not an open-market share purchase or sale, and increase his potential future equity exposure.
What is the exercise price of Marc Rubin’s new Curis (CRIS) stock options?
The granted options have an exercise price of $5.29 per share. This means Rubin can buy Curis common stock at $5.29 once the options vest, if he chooses to exercise them, regardless of the market price at that future time.
When do Marc Rubin’s newly granted Curis (CRIS) options vest?
The option grant vests as to 100% of the underlying 6,800 shares on July 7, 2027. Before that vesting date, Rubin cannot exercise these options to purchase Curis common stock. Vesting aligns the award with longer-term service to the company.
When do Marc Rubin’s Curis (CRIS) stock options expire?
The non-qualified stock options granted to Marc Rubin expire on July 6, 2036. After this expiration date, any unexercised options become worthless and can no longer be used to purchase Curis common stock at the $5.29 exercise price.
How many Curis (CRIS) derivative securities does Marc Rubin hold after this Form 4?
After this transaction, Marc Rubin holds 6,800 non-qualified stock options directly, according to the filing. The derivative summary section shows no additional remaining derivative positions beyond this grant in the reported data.
Is Marc Rubin’s Curis (CRIS) Form 4 transaction a market buy or sell?
No, this Form 4 reflects a grant or award acquisition of stock options, not an open-market buy or sell of shares. The transaction code is “A,” indicating a compensation-related award rather than a discretionary trade in Curis stock.